Explore By Subject Area   

Lead Editorial

How CMOs can Leverage AI to Streamline Clinical Development

How CMOs can Leverage AI to Streamline Clinical Development

Using personal examples, Dr Gavin Corcoran, Chief Development Officer of Formation Bio discusses where AI can positively impact clinical development and how CMOs can think about investing in AI solutions. Formation Bio acquires or in-licenses drug assets from pharma companies and biotechs to develop programs past clinical proof of concept and beyond, leveraging their proprietary tech and AI capabilities, ultimately helping to bring new medicines to patients.

Read More

More Related Content

Editorial

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.